Halozyme Therapeutics | HALO - Заемный капитал





Заемный капитал Изменить Дата
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Baxter International USD 8.62B 6M 2026-06
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 248.2M 993K 2026-06
DBV Technologies USD 0 0 2025-03
Eli Lilly USD 47.86B 8.49B 2026-06
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
MannKind USD 545.13M 2.93M 2026-06
Minerva Neurosciences USD 0 86.58M 2024-09
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Pfizer USD 60.5B 70M 2026-06
Rigel Pharmaceuticals USD 0 0 2024-09
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12